The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises

被引:18
作者
Ballas, Samir K. [1 ]
机构
[1] Thomas Jefferson Univ, Dept Med, Sidney Kimmel Med Coll, Cardeza Fdn Hematol Res, 1020 Locust St, Philadelphia, PA 19107 USA
关键词
cannabinoid; cannabis; sickle cell disease; VOC;
D O I
10.1089/can.2017.0011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The objective of this study was to determine if patients with sickle cell disease using cannabis had decreased frequency of acute vaso-occlusive crises (VOCs) that required hospitalization. Method: This was a retrospective study in which 270 urine drug screen tests were done on 72 patients: 40 males and 32 females. Results: Cannabinoids were found in 144 urine tests from 37 patients and were negative in 126 tests from 35 patients. Males who used cannabis were significantly younger (p0.001) than males who did not. Patients who tested positive used benzodiazepines, cocaine, and phencyclidine significantly more often than patients who tested negative. There was no significant difference in the amounts of opioids consumed by users and nonusers of cannabis. The cannabis cohort was seen in the clinic significantly (p0.05) less often than controls, but hospital admissions were significantly greater in the cannabis group than controls (p0.05). Conclusion: These data show an unexpected negative effect of cannabis on the frequency of VOCs. This may be due to the effect of cannabis on the brain and/or the severity of the disease in the cannabis users. More controlled studies are needed to clarify these findings.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 42 条
  • [11] Deshpande A, 2015, CAN FAM PHYSICIAN, V61, pE372
  • [12] Goals and Habits in the Brain
    Dolan, Ray J.
    Dayan, Peter
    [J]. NEURON, 2013, 80 (02) : 312 - 325
  • [13] Purified poloxamer 188 for sickle cell vaso-occlusive crisis
    Gibbs, WJ
    Hagemann, TM
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (02) : 320 - 324
  • [14] Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis A Randomized Controlled Trial
    Gladwin, Mark T.
    Kato, Gregory J.
    Weiner, Debra
    Onyekwere, Onyinye C.
    Dampier, Carlton
    Hsu, Lewis
    Hagar, R. Ward
    Howard, Thomas
    Nuss, Rachelle
    Okam, Maureen M.
    Tremonti, Carole K.
    Berman, Brian
    Villella, Anthony
    Krishnamurti, Lakshmanan
    Lanzkron, Sophie
    Castro, Oswaldo
    Gordeuk, Victor R.
    Coles, Wynona A.
    Peters-Lawrence, Marlene
    Nichols, James
    Hall, Mary K.
    Hildesheim, Mariana
    Blackwelder, William C.
    Baldassarre, James
    Casella, James F.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (09): : 893 - 902
  • [15] COMPARISON OF INTRAMUSCULAR ANALGESIC ACTIVITY OF BUTORPHANOL AND MORPHINE IN PATIENTS WITH SICKLE-CELL DISEASE
    GONZALEZ, ER
    ORNATO, JP
    WARE, D
    BULL, D
    EVENS, RP
    [J]. ANNALS OF EMERGENCY MEDICINE, 1988, 17 (08) : 788 - 791
  • [16] Grant Igor, 2012, Open Neurol J, V6, P18, DOI 10.2174/1874205X01206010018
  • [17] Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation
    Gremel, Christina M.
    Chancey, Jessica H.
    Atwood, Brady K.
    Luo, Guoxiang
    Neve, Rachael
    Ramakrishnan, Charu
    Deisseroth, Karl
    Lovinger, David M.
    Costa, Rui M.
    [J]. NEURON, 2016, 90 (06) : 1312 - 1324
  • [18] Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems A Clinical Review
    Hill, Kevin P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (24): : 2474 - 2483
  • [19] Cannabis use in sickle cell disease: a questionnaire study
    Howard, J
    Anie, KA
    Holdcroft, A
    Korn, S
    Davies, SC
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (01) : 123 - 128
  • [20] Randomised trial of oral morphine for painful episodes of sickle-cell disease in children
    Jacobson, SJ
    Kopecky, EA
    Joshi, P
    Babul, N
    [J]. LANCET, 1997, 350 (9088) : 1358 - 1361